Prostate Cancer Treatment at the University of Colorado Cancer Center
Prostate cancer is the second most prevalent type of cancer in men, but when it strikes close to home, the fight becomes personal.
You’ll find a knowledgeable, committed partner in it at The Grampsas Urologic Oncology Center at the University of Colorado Cancer Center and the University of Colorado Hospital. We specialize in the treatment and care of prostate cancer.
The region's only NCI-designated cancer center
Here, you will find caring support that rests on advanced research, technology and, not least, the kind of national experts you’d expect to find at the only National Cancer Institute-designated Comprehensive Cancer Center in the our region (and one of only 40 in the United States).
In fact, our 5-year survival rate for many kinds of cancer is up to 30% higher than state, regional and national averages.
To begin your journey with a dedicated team of prostate cancer experts, call us at (720) 848-0300.
The same caring team of doctors and support professionals is with you throughout your journey, from your initial appointment and evaluation to treatment and aftercare.
- Your team is made up of experts from many fields: surgeons, oncologists, radiologists, nurses, social workers, geneticists and counselors. Most of those you’ll meet specialize specifically in prostate cancer treatment, support and rehabilitation. They review your test results, your progress and discuss the best next step in your care with each other and with you.
- All your records, consultations, test results and provider notes about you and your treatment are in an electronic medical record, available to all of the doctors within the University of Colorado Hospital system who may be called in from all our specialties to help treat you and your condition.
- The Urologic Oncology team meets each week to review your care and progress. This approach allows us to compare notes to make sure you are receiving the most effective collaborative treatments. No other cancer center in Colorado reviews your care in this manner.
- You also have access to complementary and alternative medicine through our doctor-led Center for Integrative Medicine.
- You are treated as a whole person, to support and educate you and your entire support network. We’re also committed to promoting prostate cancer screening and prevention.
Advanced Research and Treatment
At the regional leader in cancer research, treatment and support, patients and families regularly get specialized care not available anywhere else in Colorado. You get:
- World-renowned experts in cancer diagnosis and staging (including 3-D staging), which are the first steps for getting proper cancer care.
- Advanced technologies, including robotic surgery which enables surgeons to perform even the most complex and delicate procedures through very small incisions with unmatched precision.
- Access to the use of Provenge, a therapy which trains the body's immune system to attack prostate cancer cells. The treatment involves removing the patient's own white blood cells, mixing the cells with a drug designed to target prostate cancer cells, and then re-infusing the treated blood. Provenge is FDA-approved for men who have advanced prostate cancer that is not responding to hormonal therapies.
- Access to many other new treatments, including the latest drugs and vaccines for treating prostate cancer, through our involvement in clinical trials.
Prostate Cancer at a Glance
- The prostate is a gland found only in men, located below the bladder and in front of the rectum. It contains cells that help to produce semen.
- Most prostate cancers start in the glandular cells; this is called adenocarcinoma.
- Other than skin cancer, prostate cancer is the most common cancer in American men.
- More than 217,000 new cases of prostate cancer are diagnosed each year.
- About one man in six will be diagnosed with prostate cancer during his lifetime.
- More than two million men in the United States who have been diagnosed with prostate cancer at some point are still alive today.
Source: American Cancer Society